Boston Scientific Corporation Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue5.20B5.29B5.07B5.06B4.66B4.56B4.21B4.12B
Cost of Goods Sold1.59B1.35B1.52B1.64B1.71B1.89B1.56B1.53B
Gross Profit3.61B3.94B3.54B3.42B2.95B2.67B2.65B2.58B
R&D Expenses516.0M569.0M514.0M526.0M443.0M460.0M407.0M383.0M
Operating Expenses2.54B2.73B2.49B2.60B2.05B2.08B1.97B1.84B
Operating Income1.07B1.21B1.05B819.0M896.0M589.0M674.0M747.0M
Other Income / Gains90.0M-506.0M-111.0M122.0M-91.0M-4.0M-6.0M-327.0M
Net Income1.34B668.0M755.0M793.0M674.0M566.0M469.0M324.0M
EPS (Diluted)0.900.450.510.540.4560.3840.3190.22
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.6940.7450.6990.6770.6330.5860.6290.627
General And Administrative Expenses00000000
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses1.78B1.83B1.74B1.72B1.60B1.61B1.56B1.45B
Other Expenses244.0M328.0M237.0M363.0M14.0M10.0M5.0M9.0M
Cost And Expenses4.13B4.08B4.01B4.24B3.77B3.97B3.54B3.37B
Interest Income0000022.0M00
Interest Expense90.0M90.0M87.0M90.0M87.0M139.0M83.0M81.0M
Depreciation And Amortization00342.0M336.0M325.0M348.0M307.0M311.0M
Ebitda1.07B956.0M1.37B1.37B1.22B1.07B1.06B812.0M
Ebitdaratio0.2060.1810.270.270.2610.2350.2510.197
Operating Income Ratio0.2060.2280.2070.1620.1920.1290.160.181
Income Before Tax1.16B700.0M939.0M941.0M805.0M585.0M668.0M420.0M
Income Before Tax Ratio0.2230.1320.1850.1860.1730.1280.1590.102
Income Tax Expense-176.0M31.0M183.0M146.0M133.0M23.0M200.0M98.0M
Net Income Ratio0.2570.1260.1490.1570.1450.1240.1110.079
Epsdiluted0.900.450.500.530.4510.380.3150.218
Weighted Average Shs Out1.48B1.48B1.48B1.48B1.48B1.47B1.47B1.47B
Weighted Average Shs Out Dil1.50B1.50B1.50B1.49B1.49B1.49B1.49B1.48B